Overview

NRA-CANDESARTAN HCTZ 32 MG contains CANDESARTAN CILEXETIL : 32 MG HYDROCHLOROTHIAZIDE : 25 MG. It is listed in the Health Canada Drug Product Database under DIN 02531267, held by NORA PHARMA INC, supplied as TABLET for ORAL administration. Nexara Health is a licensed Canadian wholesale distributor and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

Product details

Indications

Treatment of essential hypertension in patients for whom combination therapy is appropriate. Not indicated for initial therapy.

Dosage and administration

Individualized by titration of components. Once stabilized, take one tablet daily at the same time, with or without food. Not for initial therapy.

Contraindications

Hypersensitivity to ingredients or sulfonamides; anuria; pregnancy; nursing; children <1 year; combination with aliskiren in diabetes/renal impairment; severe hepatic/renal impairment; gout.

Warnings and precautions

Fetal toxicity; dual blockade of RAS; hypotension; non-melanoma skin cancer risk; electrolyte imbalance; systemic lupus erythematosus exacerbation; acute myopia/glaucoma.

Storage and handling

Not explicitly stated in the provided text (section 11 is listed in TOC but content is missing), though typically room temperature.

Packaging

Bottles of 30, 100, or 1000 tablets; Blister packs of 30 or 80 tablets.

Alternatives in the same therapeutic class

Products sharing ATC code C09DA06 CANDERSARTAN AND DIURETICS. Marketed products are listed first. Substitution decisions rest with the prescriber or pharmacist, and interchangeability is determined provincially.